COMMERCIALIZING A BREAKTHROUGH ANTIMICROBIAL PLATFORM
PhotoDynamic is building a leading edge antimicrobial platform, with the impact of treatment and the power prevention, balancing safety and efficacy.
Our technology addresses significant market opportunities in both OTC and Rx.
TECHNOLOGY
SAFETY AND EFFICACY
The clinically proven efficacy of our technology is based on a natural plant extract with a long history of safe human use, combined with light from the safe visible spectrum.
PREVENTION
The powerful antimicrobial activity of our technology prevents the harmful impacts of topical pathogens.
TREATMENT
Successful treatment outcomes targeting a convenient, easy to use delivery format.
ORAL HEALTH ANTIMICROBIAL PLATFORM
PhytoLight - Now available in North America
®
Our breakthrough oral hygiene technology is now Health Canada and U.S. FDA approved, currently adopted by, and available in, clinics in the U.S. and Canada.
PhytoLight - The new standard of at-home oral health care.
SOLUTIONS AND MARKETS
PHOTODYNAMIC TEAM
YING TAM
CEO and Board Chair
Ying Tam is a serial entrepreneur who has co-founded and scaled several startup companies to successful exits. He is a seasoned business executive with significant strategic and operational experience, holding operating roles in a wide range of organizations, from startup/early-stage companies to major multinational corporations. Previously, his roles include COO at a digital health startup building a conversational AI platform, CEO of an early-stage mid-market ERP software company, and vice president in the Management Consulting Practice at Ernst & Young.
MARTIN GREENWOOD
VP and Board Member
As VP Commercialization for a natural health product company that grew to $12M in sales, Martin has participated in raising over $15M in investment and has experience building a product pipeline with annual sales approaching $10M.
DR. SHERRI MCFARLAND
CSO and Board Member
As an expert in designing synthetic photosensitizers and in formulating plant extracts for photodynamic applications, specifically in the photodynamic inactivation (PDI) of bacteria and also photodynamic therapy (PDT) of cancer, Sherri is a leading expert in light therapies.
DR. ALEXANDER MCLELLAN
VP Regulatory & Clinical
With 25 years of experience in the natural health product industry, including acting as the CSO for a start-up natural health product company that grew to $12M in sales. Alex has a diverse technical and business background, including securing R&D funding, managing research collaborations, and managing regulatory strategy and submissions.
DR. COLIN CAMERON
VP Engineering
As an expert in polymer and analytical chemistry and LED fabrication, Colin designs proprietary light delivery systems that are used to activate photosensitizers (PSs) for a range of applications.
JASON TUTTY
VP Sales & Marketing
Jason has a combined total of more than 28 years experience in marketing, sales, communications, executive management, merchandising, brand management/development, PR, market research, forecasting, regulatory affairs and business development.
SUSAN MONRO
Lab & Quality Lead
As a hands-on researcher with proficiency in organic and inorganic synthesis, natural products chemistry, biological chemistry, and screening for photodynamic activity, Susan manages our lab facilities and ensures quality control.
CATHERINE MCGUIRE
Manufacturing Lead
With over 25 years of experience implementing creative processes to improve production, logistics, and quality, Catherine is managing logistics and operations at PDI.
OUR STORY
PhotoDynamic founder Sherri McFarland, a world leader in photochemistry specializing on PhotoDynamic Therapy a Cancer therapy, extended her research to PhotoDynamic Inactivation to investigate whether invasive plant species might also be a repository of photoactive agents with therapeutic potential. She reasoned that photodynamic compounds naturally derived by the plants and activated by sunlight may explain how invasive plants become the super-plants they are.
Through this work Sherri discovered the powerful antimicrobial properties of Japanese Knotweed (JK). Balancing the intrinsic safety of JK with breakthrough efficacy against viral, bacterial and fungal pathogens, this novel platform promises a brand new class of OTC preventative therapies and Rx treatments.
PhotoDynamic Inc was created to commercialize this novel antimicrobial platform.
BOARD
YING TAM
CEO and Board Chair
Ying Tam is a serial entrepreneur who has co-founded and scaled several startup companies to successful exits. He is a seasoned business executive with significant strategic and operational experience, holding operating roles in a wide range of organizations, from startup/early-stage companies to major multinational corporations. Previously, his roles include COO at a digital health startup building a conversational AI platform, CEO of an early-stage mid-market ERP software company, and vice president in the Management Consulting Practice at Ernst & Young.
MARTIN GREENWOOD
VP and Board Member
As VP Commercialization for a natural health product company that grew to $12M in sales, Martin has participated in raising over $15M in investment and has experience building a product pipeline with annual sales approaching $10M.
DR. MICHAEL SHERMAN
Board Member
Dr. Michael Sherman is a certified specialist in orthodontics. In addition to being a published author and a public lecturer, Dr. Sherman is a Trustee on the Board of the American Orthodontic Association (AAO), and a past President of the Great Lakes Association of Orthodontists and the Ontario Association of Orthodontists.
DR. SHERRI MCFARLAND
CSO and Board Member
As an expert in designing synthetic photosensitizers and in formulating plant extracts for photodynamic applications, specifically in the photodynamic inactivation (PDI) of bacteria and also photodynamic therapy (PDT) of cancer, Sherri is a leading expert in light therapies.
NEWS
PHOTODYNAMIC BEGINS CONTROLLED LAUNCH OF PHYTOLIGHT
PHOTODYNAMIC'S TECNOLOGY SHOWS ANTI CORONAVIRUS ACTIVITY
PHYTOLIGHT, PHOTODYNAMIC'S AT HOME ORAL HYGIENE SOLUTION, FEATURED IN ORALHEALTH MAGAZINE
PHOTODYNAMIC SECURES INVESTMENT FROM THE AMERICAN ASSOCIATION OF ORTHODONTISTS TO CLOSE $2.3M ROUND
PHOTODYNAMIC PRESENTS FORSYTH CLINICAL RESULTS
PHOTODYNAMIC PLANS MAJOR PRODUCT LAUNCH
PHOTODYNAMIC EXCEEDS EXPECTATIONS IN CLINICAL TRIAL
PHOTODYNAMIC RESEARCH ON THE COVER
OF LEADING SCIENTIFIC JOURNAL
EVIDENCE LACKING FOR DENTAL INTERVENTIONS IN BIOFILM CONTROL
®
